Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model
Therapeutic antibodies are often prescribed off-label to pregnant patients to treat inflammatory, autoimmune, or malignant conditions. Despite their broad use, the extent of fetal exposure to such therapeutic antibodies and the risk to fetal development remain largely unknown. Given the ethical chal...
Saved in:
Published in | Clinical pharmacology and therapeutics Vol. 118; no. 2; p. 394 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.08.2025
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!